Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, an experimental oral glucosylceramide synthase…
Sanofi's Board of Directors has proposed the appointment of Christel Heydemann as an independent director, which will be submitted for shareholder app…
Sanofi and Regeneron announce the FDA approval of Dupixent (dupilumab) for treating allergic fungal rhinosinusitis in adults and children aged 6 years…
Sanofi and Teva have announced positive phase IIb maintenance results for duvakitug, a monoclonal antibody targeting TL1A, in the treatment of ulcerat…
Sanofi reports on the results of a population study conducted in Galicia showing that Beyfortus (nirsevimab), its immunization against respiratory syn…
The Board of Directors of Sanofi has decided not to renew the mandate of Paul Hudson and has appointed Belén Garijo as the CEO. Belén Garijo will assu…
Sanofi's stock experienced a sharp decline this Thursday morning, dropping 4.71% to 78.67 euros amid changes at the helm of the pharmaceutical group. …
Sanofi shares increased by 1.78% this Tuesday morning, February 10, reaching 81.72 euros. This rebound follows the announcement of a major designation…
On February 10, 2026, Sanofi announced the completion of the acquisition of Dynavax Technologies Corporation, in accordance with the terms of the tend…
The FDA has granted rilzabrutinib (Wayrilz) a breakthrough therapy designation for warm antibody autoimmune hemolytic anemia, while Japan has granted …
